TubA,behaving as a selective HDAC6 inhibitor, and RSV, through pan-HDACinhibition and PPARγ activation, served as chemical probes fora deeper understanding of CF cell signaling related to tubulin acetylationstatus, thus providing a glimpse of a new therapeutic avenue for effectivereversal of CF phenotype. This evidence concerns the gene PPARG and cystic fibrosis.